Rosenblatt L - Search Results

1

Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214.

Mantia CM, Jegede OA, Plimack ER, Powles T, Motzer RJ, Tannir NM, Lee CH, Tomita Y, Voss MH, Choueiri TK, Rini BI, Hammers HJ, Escudier B, Albigès L, Rosenblatt L, Atkins MB, Regan MM, McDermott DF. Mantia CM, et al. Among authors: rosenblatt l. J Immunother Cancer. 2024 Jul 25;12(7):e009495. doi: 10.1136/jitc-2024-009495. J Immunother Cancer. 2024. PMID: 39060019 Free PMC article. Clinical Trial.

2

Long-Term Temporal Trends of Real-World Healthcare Costs Associated with Nivolumab Plus Ipilimumab and Pembrolizumab Plus Axitinib as First-Line Treatment for Advanced or Metastatic Renal Cell Carcinoma.

Du EX, Betts KA, Wang T, Kitchen SA, He X, Yin X, Guttenplan SB, Beauchamp K, Delgado A, Rosenblatt L. Du EX, et al. Among authors: rosenblatt l. Oncol Ther. 2024 Dec;12(4):735-751. doi: 10.1007/s40487-024-00297-0. Epub 2024 Aug 10. Oncol Ther. 2024. PMID: 39127872 Free PMC article.

3

Costs of Adverse Events in Patients with Advanced or Metastatic Renal Cell Carcinoma with First-Line Treatment.

Chen Y, Du EX, Sundar M, Betts KA, Yin X, Eiffert S, Beauchamp K, Delgado A, Rosenblatt L. Chen Y, et al. Among authors: rosenblatt l. Pharmacoecon Open. 2025 Jan;9(1):125-136. doi: 10.1007/s41669-024-00534-2. Epub 2024 Nov 6. Pharmacoecon Open. 2025. PMID: 39505818 Free PMC article.

4

Racial differences in real-world outcomes of first-line therapies for advanced renal cell carcinoma.

Geynisman DM, John WS, Miller TA, Asgarisabet P, Guttenplan SB, Yin X, Savill KMZ, McAllister L, Rosenblatt L. Geynisman DM, et al. Among authors: rosenblatt l. Oncologist. 2024 Dec 19:oyae354. doi: 10.1093/oncolo/oyae354. Online ahead of print. Oncologist. 2024. PMID: 39703163 Free article.

5

Treatment Preferences Among Patients with Renal Cell Carcinoma: Results from a Discrete Choice Experiment.

Ornstein MC, Rosenblatt LC, Yin X, Del Tejo V, Guttenplan SB, Ejzykowicz F, Beusterien K, Will O, Mackie DS, Skiles G, DeCongelio M. Ornstein MC, et al. Among authors: rosenblatt lc. Patient Prefer Adherence. 2024 Aug 15;18:1729-1739. doi: 10.2147/PPA.S460994. eCollection 2024. Patient Prefer Adherence. 2024. PMID: 39161803 Free PMC article.

6

Treatment Patterns and Survival Outcomes Among Androgen Receptor Pathway Inhibitor-Experienced Patients With Metastatic Castration-Resistant Prostate Cancer.

Narayan V, Patel MY, Teitsson S, Rosenblatt L, Yin X, Pivneva I, Gao S, Sundar M, Betts KA. Narayan V, et al. Among authors: rosenblatt l. Clin Genitourin Cancer. 2024 Dec;22(6):102188. doi: 10.1016/j.clgc.2024.102188. Epub 2024 Aug 8. Clin Genitourin Cancer. 2024. PMID: 39232487 Free article.

7

Treatment Patterns and Costs Among Patients With Metastatic Renal Cell Carcinoma in the United States: A Real-World Study Using Integrated Claims and Clinical Data.

Geynisman DM, Hill NR, Rosenblatt LC, Yin X, Haley VB, Barron JJ, Nguyen C, Vilanova D, George S. Geynisman DM, et al. Among authors: rosenblatt lc. JCO Oncol Pract. 2025 Jan 6:OP2400564. doi: 10.1200/OP-24-00564. Online ahead of print. JCO Oncol Pract. 2025. PMID: 39761490

8

Real-World Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Nivolumab Plus Ipilimumab in the United States.

Doshi GK, Osterland AJ, Shi P, Yim A, Del Tejo V, Guttenplan SB, Eiffert S, Yin X, Rosenblatt L, Conkling PR. Doshi GK, et al. Among authors: rosenblatt l. JCO Clin Cancer Inform. 2024 Dec;8:e2400132. doi: 10.1200/CCI.24.00132. Epub 2024 Dec 20. JCO Clin Cancer Inform. 2024. PMID: 39705641 Free PMC article.

9

Temporal trends in anticoagulation use and clinical outcomes among medicare beneficiaries with non-valvular atrial fibrillation.

Atwater BD, Guo JD, Keshishian A, Delinger R, Russ C, Rosenblatt L, Jiang J, Yuce H, Ferri M. Atwater BD, et al. Among authors: rosenblatt l. J Thromb Thrombolysis. 2024 Jan;57(1):1-10. doi: 10.1007/s11239-023-02838-2. Epub 2023 Aug 2. J Thromb Thrombolysis. 2024. PMID: 37530955 Free PMC article.

10

Immune-based Therapies-What the Emergency Physician Needs to Know.

Dubbs SB, Falat C, Rosenblatt L. Dubbs SB, et al. Among authors: rosenblatt l. Immunol Allergy Clin North Am. 2023 Aug;43(3):569-582. doi: 10.1016/j.iac.2022.10.004. Immunol Allergy Clin North Am. 2023. PMID: 37394260 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters